Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01389518Phase 3Completed
Phase 3, randomised, double-blind trial of acetaminophen, chlorpheniramine and phenylephrine in common cold and influenza (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Symptom score at 72 hours. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01389518.